Codexis, Inc. is an industrial biotechnology company that specializes in engineers enzymes for pharmaceutical and chemical production through biocatalysis. Codexis’ technologies enable scale-up and implementation of biocatalytic solutions to optimize process development, from research to manufacturing. There are currently over 50 pharmaceutical firms using Codexis’ technology, products and services in their manufacturing process development.
Codexis creates its products by applying its CodeEvolver® directed evolution technology platform, which introduces genetic mutations into microorganisms.
Codexis, Inc. began operations as an independent company in 2002, and became a publicly traded company in 2009. They are located in Redwood City, CA USA

Type
Public
HQ
Redwood City, US
Founded
2002

Key People at Codexis

Douglas Sheehy

Douglas Sheehy

Executive Vice President, Chief Administrative Officer, General Counsel, and Secretary
David O'Toole

David O'Toole

Senior Vice President and Chief Financial Officer
John Nicols

John Nicols

President & CEO
James Lalonde

James Lalonde

Senior Vice President, Research & Development

Codexis Locations

Redwood City, US

Codexis Metrics

Codexis Summary

Founding Date

2002

Market capitalization

$192 M

Closing share price

$4.75

Codexis Market Value History

Codexis Online Presence

Codexis Company Life

You may also be interested in